Breaking News Instant updates and real-time market news.

KEY

KeyCorp

$21.44

0.26 (1.23%)

, SYMC

Symantec

$18.66

-0.15 (-0.80%)

17:35
08/14/18
08/14
17:35
08/14/18
17:35

Appaloosa adds KeyCorp, exits NVIDIA

David Tepper's Appaloosa disclosed in an SEC filing its holdings as of June 30, 2018. The fund's six new buys included, by size of position, KeyCorp (KEY), Symantec (SYMC), Citizens Financial (CFG), Vistra Energy (VST), and New Oriental Education & Technology Group (EDU). The fund exited 11 positions during the quarter, including by size of previous position Invesco QQQ Trust Series 1 (QQQ), Applied Materials (AMAT), VanEck Vectors Semiconductor ETF (SMH), Allstate (ALL), and NVIDIA (NVDA). Appaloosa increased its stake in 11 holdings, including by size of previous position Micron (MU), Western Digital (WDC), Cheniere Energy (LNG), Wells Fargo (WFC), and Platform Specialty Products (PAH). The fund reduced its stake in 29 holdings, including by size of previous position Alibaba (BABA), NRG Energy (NRG), Bank of America (BAC), MGM Resorts (MGM), and Ally Financial (ALLY). Appaloosa's top holdings as of June 30, in order of size, were Micron, Facebook (FB), Allergan (AGN), Alibaba, and Alphabet Class C (GOOG).

KEY

KeyCorp

$21.44

0.26 (1.23%)

SYMC

Symantec

$18.66

-0.15 (-0.80%)

CFG

Citizens Financial

$40.39

0.54 (1.36%)

VST

Vistra Energy

$22.41

0.31 (1.40%)

EDU

New Oriental Education

$85.07

-0.08 (-0.09%)

QQQ

Invesco QQQ Trust

$181.44

1.1 (0.61%)

AMAT

Applied Materials

$48.38

0.12 (0.25%)

SMH

Market Vectors Semiconductor

$105.49

-0.25 (-0.24%)

ALL

Allstate

$98.35

0.2 (0.20%)

NVDA

Nvidia

$261.47

5.39 (2.10%)

MU

Micron

$50.62

-0.73 (-1.42%)

WDC

Western Digital

$64.98

0.75 (1.17%)

LNG

Cheniere Energy

$63.48

-0.13 (-0.20%)

WFC

Wells Fargo

$58.07

0.43 (0.75%)

PAH

Platform Specialty Products

$12.26

0.08 (0.66%)

BABA

Alibaba

$172.53

-5.12 (-2.88%)

NRG

NRG Energy

$32.83

0.33 (1.02%)

BAC

Bank of America

$30.80

0.33 (1.08%)

MGM

MGM Resorts

$28.99

-0.04 (-0.14%)

ALY

Allis-Chalmers

$0.00

(0.00%)

FB

Facebook

$181.11

1.03 (0.57%)

AGN

Allergan

$184.44

0.18 (0.10%)

GOOG

Alphabet

$1,241.95

6.85 (0.55%)

  • 14

    Aug

  • 14

    Aug

  • 16

    Aug

  • 16

    Aug

  • 22

    Aug

  • 23

    Aug

  • 05

    Sep

  • 10

    Sep

  • 11

    Sep

  • 12

    Sep

  • 20

    Sep

  • 27

    Sep

  • 01

    Oct

  • 18

    Oct

  • 19

    Oct

  • 28

    Oct

  • 30

    Oct

  • 12

    Apr

  • 13

    Jul

  • 15

    Oct

KEY KeyCorp
$21.44

0.26 (1.23%)

06/26/18
ARGS
06/26/18
INITIATION
Target $24
ARGS
Buy
KeyCorp initiated with a Buy at Argus
Argus analyst Stephen Biggar initiated KeyCorp with a Buy rating and a price target of $24, saying the company's earnings trend should outpace that of its peers thanks to its positive loan growth, net interest margin expansion, and strong credit quality. The analyst is also positive on the impact of the regulatory rollback to Dodd-Frank Act toward the regional banking sector. Biggar states that his target on KeyCorp implies a 14-times PE valuation multiple and represents a "modest premium" to the 13-times average for its regional bank peers, which is justifiable by its growth profile as well as its better return on equity and efficiency ratio metrics.
06/26/18
ARGS
06/26/18
INITIATION
Target $24
ARGS
Buy
KeyCorp initiated with a Buy at Argus
06/29/18
WEDB
06/29/18
NO CHANGE
WEDB
Outperform
CCAR results 'very positive' for regional banks, says Wedbush
Wedbush analyst Peter Winter says the results of the CCAR for 2018 were "very positive" for the regional banks, as the average total capital return increased from 88% in the 2017 CCAR to 119%, above his forecast of 103%. In a research note to investors, Winter says the "winners" relative to his forecast were Regions Financial (RF), Huntington Bancshares (HBAN), Fifth Third (FITB), SunTrust (STI) and KeyCorp (KEY).
06/29/18
DBAB
06/29/18
NO CHANGE
DBAB
Deutsche declares Wells Fargo, SunTrust, Huntington the CCAR winners
Deutsche Bank analyst Matt O'Connor views Wells Fargo (WFC), SunTrust (STI) and Huntington Bancshares (HBAN) as the winners of the Federal Reserve's Comprehensive Capital Analysis and Review. The banks separately disclosed planned dividend increases and buybacks for the next four quarters, O'Connor tells investors in a research note. He points out that while JPMorgan (JPM), KeyCorp (KEY) and M&T Bank (MTB) "all used the mulligan," he does not view this as negative.
SYMC Symantec
$18.66

-0.15 (-0.80%)

05/16/18
05/16/18
DOWNGRADE
Target $24.5

Neutral
Symantec downgraded to Neutral, another transition year ahead, says Goldman
As previously reported, Goldman downgraded Symantec to Neutral from Buy with a $24.50 price target. Analyst Gabriela Borges expects FY19 to be another transition year with respect to investments, product mix and competitive positioning, compounded by an overhang in the stocks multiple from the May 10 audit investigation.
05/16/18
GSCO
05/16/18
DOWNGRADE
GSCO
Neutral
Symantec downgraded to Neutral from Buy at Goldman Sachs
05/15/18
DBAB
05/15/18
NO CHANGE
Target $22
DBAB
Hold
Symantec call lessened near-term risk, says Deutsche Bank
The belated Q&A call hosted by Symantec, where management said they are not expecting a material adverse impact on the company's financials from the audit investigation, lessened the near-term risk, Deutsche Bank analyst Karl Keirstead tells investors in a research note. The analyst believes, however, that the audit probe risk will linger. Nonetheless, he concludes that the debate will now pivot to the likelihood of Symantec hitting "what looks like aggressive" fiscal 2020 targets. Keirstead keeps a Hold rating on the shares with a $22 price target.
05/15/18
JEFF
05/15/18
UPGRADE
Target $22
JEFF
Hold
Symantec upgraded to Hold from Underperform at Jefferies
Jefferies analyst John DiFucci upgraded Symantec to Hold and raised his price target for the shares to $22 from $20. While difficult, if not impossible, to assess the outcome of the current investigation, there's a base value for the business that is not far from the current price, DiFucci tells investors in a research note. He points out, however, that it "remains unclear whether the company will return to growth."
CFG Citizens Financial
$40.39

0.54 (1.36%)

04/23/18
BMOC
04/23/18
NO CHANGE
Target $52
BMOC
Outperform
Citizens Financial price target lowered to $52 from $56 at BMO Capital
BMO Capital analyst Lana Chan lowered her price target on Citizens Financial to $52, saying that despite the Q1 earnings beat, the underlying trends were mixed with weak loan growth and weak fees along with a lower loan loss provision and better net interest margins. Chan keeps her Outperform rating on Citizens Financial, maintaining her positive outlook toward improvement in "below-peer profitability metrics through balance sheet optimization, improved fee income productivity, and higher capital returns".
05/30/18
BARD
05/30/18
UPGRADE
Target $46
BARD
Outperform
Citizens Financial upgraded to Outperform at Baird
As reported previously, Baird analyst David George upgraded Citizens Financial to Outperform from Neutral. The analyst cited yesterday's weakness as a buying opportunity as the Italian bond and U.S. Treasury yields weighed on the banks. He likes the improving operating leverage, capital return, and discounted valuation of Citizens and maintained his $46 price target on the shares.
04/23/18
SDLR
04/23/18
UPGRADE
SDLR
Buy
Citizens Financial upgraded to Buy from Hold at Sandler O'Neill
05/30/18
BARD
05/30/18
UPGRADE
BARD
Outperform
Citizens Financial upgraded to Outperform from Neutral at Baird
VST Vistra Energy
$22.41

0.31 (1.40%)

05/01/18
SBSH
05/01/18
INITIATION
Target $27
SBSH
Buy
Vistra Energy reinstated with a Buy at Citi
Citi analyst Praful Mehta reinstated coverage of Vistra Energy with a Buy rating and raised his price target for the shares to $27 from $22. Vistra is well positioned to benefit from the market tightening in Texas, Mehta tells investors in a research note. He also expects management to start a dividend, which he feels will help attract a stable investor base.
03/28/18
MACQ
03/28/18
INITIATION
Target $24
MACQ
Outperform
Vistra Energy initiated with an Outperform at Macquarie
Macquarie started Vistra Energy with an Outperform rating and $24 price target.
03/06/18
UBSW
03/06/18
UPGRADE
Target $27
UBSW
Buy
Vistra Energy upgraded to Buy from Neutral at UBS
UBS analyst Daniel Ford upgraded Vistra Energy (VST) to Buy and raised his price target for the shares to $27 from $21 and after incorporating the Dynegy (DYN) merger into his model. Management indicated that forecast synergies and operational improvements could be increased, which provides more confidence in achievement of the base forecast of $350M, Ford tells investors in a research note.
02/23/18
UBSW
02/23/18
INITIATION
Target $21
UBSW
Neutral
Vistra Energy initiated with a Neutral at UBS
UBS analyst Daniel Ford started Vistra Energy (VST) with a Neutral rating and $21 price target. The analyst views the shares as fairly valued without the Dynegy (DYN) deal and prefers shares of NRG Energy (NRG).
EDU New Oriental Education
$85.07

-0.08 (-0.09%)

06/14/18
JEFF
06/14/18
NO CHANGE
Target $42.5
JEFF
Buy
Jefferies keeps Buy rating on TAL, says fraud claims are serious
While Muddy Waters' report did not relate to TAL Education's (TAL) core businesses, the fraud claims are serious nonetheless and would cast concerns over the company's integrity should management be unable to provide a satisfactory explanation, Jefferies analyst Johnny Kin Man Wong tells investors in a research note. The analyst expects share price volatility and notes that New Oriental Education's (EDU) stock price fell from $22.26 to $9.47, or 57.5%, over the course of two days when similar short reports arose in July 2012. Wong has a Buy rating on TAL Education with a $42.50 price target.
05/24/18
LYON
05/24/18
DOWNGRADE
LYON
Underperform
New Oriental Education downgraded to Underperform from Outperform at CLSA
07/26/18
JPMS
07/26/18
UPGRADE
Target $113
JPMS
Overweight
New Oriental Education upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Leon Chik upgraded New Oriental Education to Overweight and raised his price target for the shares to $113 from $102. The company's Q4 results are better than they look, Chik tells investors in a post-earnings research note.
06/29/18
06/29/18
NO CHANGE

Morgan Stanley shakes up China Education ratings, ups Bright Scholar, cuts TAL
As previously reported, Morgan Stanley analyst Sheng Zhong upgraded Bright Scholar (BEDU) to Overweight from Equal Weight and downgraded TAL Education (TAL) to Equal Weight from Overweight, telling investors in a note on the China Education sector that she now prefer stocks with a balanced growth outlook and valuation given China's regulatory and operational uncertainties. The analyst, who still prefers companies focused on after-school tutoring, called Rise Education (REDU) and New Oriental Education (EDU) her top picks in the space. Zhong also downgraded Four Seasons Education (FEDU) to Equal Weight and cut her rating on OneSmart Education (ONE) to Equal Weight from Overweight.
QQQ Invesco QQQ Trust
$181.44

1.1 (0.61%)

AMAT Applied Materials
$48.38

0.12 (0.25%)

08/13/18
STFL
08/13/18
NO CHANGE
STFL
Buy
3D NAND benefits equipment suppliers, advanced materials, says Stifel
Stifel analyst Patrick Ho tells investors in a research note that, following last week's Flash Memory Summit, the transition by the NAND industry to 96 layers and above will be the catalyst for a further step up in capital intensity trends for materials-enabled processes. He believes the comments and presentations that emerged from the conference continue to support his favorable view on names like Applied Materials (AMAT), KLA-Tencor (KLAC), Lam Reserach (LRCX) and MKS Instruments (MKSI), but believes another group that will benefit are materials/chemistries companies like Entegris (ENTG) and Versum Materials (VSM).
08/09/18
08/09/18
DOWNGRADE
Target $54

Equal Weight
Morgan Stanley more cautious on semi equipment, downgrades Applied Materials
As previously reported, Morgan Stanley analyst Joseph Moore downgraded Applied Materials (AMAT) to Equal Weight from Overweight, as he said he is concerned by the fact that the certainty of semiconductor capital equipment vendors "seems much higher than the conviction of the spenders." He would expect Applied Materials to express a sense of optimism about the recovery when it reports earnings next week, similar to the June quarters from equipment vendors, which he said should help the stock. However, Moore views the first quarter of 2018 as the peak and forecasts declines of about 10% next year. He lowered his price target on Applied shares to $54 from $58. Moore, who sees equipment stocks as more range-bound for the next 6-12 months, also lowered his semiconductor capital equipment industry view to In-Line from Attractive.
08/09/18
MSCO
08/09/18
DOWNGRADE
MSCO
Equal Weight
Applied Materials downgraded to Equal Weight from Overweight at Morgan Stanley
08/06/18
STFL
08/06/18
NO CHANGE
STFL
Stifel says Applied, Lam to be beneficiaries of NAND capital intensity step-up
Ahead of this week's upcoming Flash Memory Summit, Patrick Ho shared his view of how he expects capital intensity trends continue to increase as the NAND industry moves to 96 layers and above over the next few years. From a stocks perspective, he believes the biggest beneficiaries of the step-up will remain Applied Materials (AMAT) and Lam Research (LRCX), while also noting that MKS Instruments (MKSI) can benefit from its leadership position in many areas where it supplies both Applied and Lam. Stating that he supports Ho's view on the memory industry's increasing capital intensity, Stifel analyst Kevin Cassidy said in his own note to investors that he expects FMS conference keynotes to discuss the expanding markets for NAND Flash pushing total revenue and profits up despite the industry's increasing capital expenditures driving average selling prices lower. Cassidy also noted the first ever MRAM Developers Day will be held Monday, August 6, stating that he views this as significant for expanding the MRAM eco-system led by Everspin (MRAM). Other NAND Flash names Cassidy has previously been positive about include Micron (MU) and Smart Global (SGH).
SMH Market Vectors Semiconductor
$105.49

-0.25 (-0.24%)

ALL Allstate
$98.35

0.2 (0.20%)

07/18/18
BUCK
07/18/18
UPGRADE
BUCK
Neutral
Allstate upgraded to Neutral from Underperform at Buckingham
08/07/18
FBCO
08/07/18
INITIATION
Target $73
FBCO
Outperform
Progressive initiated with an Outperform at Credit Suisse
Credit Suisse analyst Michael Zaremski started Progressive (PGR) with an Outperform rating and $73 price target. The analyst believes telematics has been and will continue to be a profitability game changer, and thinks Progressive, and to a lesser extent, Allstate (ALL), have huge leads on the competition, which he feels will afford them competitive advantages for years to come. Zaremski estimates Progressive has telematics data on approximately 25% of its customers, and expects this number to more than double in the coming 24 months, which will enable Progressive to further refine its underwriting factors to price risk more accurately and continue attracting the industry's best risks.
07/18/18
BUCK
07/18/18
UPGRADE
Target $88
BUCK
Neutral
Allstate upgraded to Neutral from Underperform at Buckingham
As previously reported, Buckingham upgraded Allstate to Neutral from Underperform. Analyst Amit Kumar raised his view citing valuation and maintained a $88 price target on shares.
08/07/18
FBCO
08/07/18
INITIATION
Target $114
FBCO
Outperform
Allstate initiated with an Outperform at Credit Suisse
Credit Suisse analyst Michael Zaremski started Allstate with an Outperform rating and $114 price target. The analyst believes Telematics is a profitability game changer, especially since Progressive (PGR) and Allstate have a huge lead on the competition. Zaremski thinks both companies are in the early innings of deploying their telematics data to improve their underwriting, claims, and marketing capabilities. Allstate has roughly 1M policyholders that are using its app or plug-in device, representing about 5% of its customer base, he notes, adding he expects this number to more than double in the coming 18 months, which will provide Allstate with enough data to extrapolate predictive analytics across its entire portfolio to price risk more accurately.
NVDA Nvidia
$261.47

5.39 (2.10%)

08/13/18
MKMP
08/13/18
NO CHANGE
Target $255
MKMP
Neutral
Nvidia to stay rangebound on moderated gaming and crypto view, says MKM Partners
MKM Partners analyst Ruben Roy kept his Neutral rating and $255 price target on Nvidia ahead its earnings this week, saying the investor sentiment on the stock is "somewhat muted". The analyst notes that the weakness in its Cryptocurrency/blockchain business was highlighted throughout the reported quarter and also sees some moderation in its gaming expectations. Roy remains upbeat about Nvidia's longer term prospects, but believes that its premium valuation will keep the stock rangebound in the short run.
08/14/18
EVER
08/14/18
NO CHANGE
EVER
Nvidia 'remains unquestionably' the leader in graphics, says Evercore ISI
After Nvidia yesterday unveiled its new Quadro GPU family, Evercore ISI analyst C.J. Muse says the company remains, "unquestionably," the worldwide leader in graphics. The Quadro GPU family should drive accelerated growth in Nvidia's Pro-Viz business, Muse tells investors in a research note. He believes the company continues to build the defacto standard for artificial intelligence with its CUDA platform creating a "sustainable advantage." He looks for Nvidia to exit 2018 at an earnings per share run-rate of $9-plus, above today's consensus estimate of $8.24. Muse sees "clear support" for his $11 earnings run-rate by 2020, which he says makes his $275 price target "likely conservative." The analyst reiterates an Outperform rating on shares of Nvidia. The stock in midday trading is up $4.81 to $260.93.
08/10/18
JEFF
08/10/18
NO CHANGE
Target $320
JEFF
Buy
Nvidia expectations low into Q2 results, says Jefferies
Jefferies analyst Mark Lipacis sees low expectations for Nvidia into the company's Q2 results. He thinks expectations are low due to a $200M quarter-over-quarter decline in cryptocurrency revenue, the company's Pascal gaming GPU being two years old, and the Street's call for a 130 basis point quarter-over-quarter gross margin. The analyst is a buyer of Nvidia shares. He expects a new gaming GPU in Q3 to drives sales in Q4 and 2019. Lipacis keeps a Buy rating on the shares with a $320 price target.
08/13/18
COWN
08/13/18
NO CHANGE
Target $325
COWN
Outperform
Nvidia setup favorable heading into Q2 results, says Cowen
Cowen analyst Matthew Ramsay sees a favorable setup for Nvidia heading into Q2 results. He noted the well-documented choppiness in the gaming channel which will be offset by continued robust data center demand and backlog. He sees little risk to near-term numbers from crypto as the company de-risked it with earlier guidance. Ramsay reiterated his Outperform rating and $325 price target on Nvidia shares.
MU Micron
$50.62

-0.73 (-1.42%)

08/01/18
CHLM
08/01/18
NO CHANGE
Target $60
CHLM
Buy
Worries about SK Hynix impact on Silicon Motion overdone, says Craig-Hallum
Craig-Hallum analyst Anthony Stoss said investors have remained fearful for years about Silicon Motion (SIMO) losing SK Hynix, but he believes the worries, which have resurfaced, are overdone as he believes Micron's (MU) UFS business and new open channel opportunities should offset a decline in the company's eMMC revenues from Hynix. Stoss thinks Silicon Motion didn't raise FY18 guidance as they are only including a partial amount of an $11M-$15M project push out in their Q4 expectations, but also noted that the company raised its expected Client SSD business growth view to at least 30% this year from about 20%. Stoss, who thinks Silicon Motion could still raise its FY18 guidance, reiterates his Buy rating and $60 price target on the stock.
08/09/18
MSCO
08/09/18
NO CHANGE
MSCO
Morgan Stanley downgrades semiconductor industry view to Cautious
Morgan Stanley analyst Joseph Moore said he has become less constructive on semiconductor stocks through the year and he now believes elevated inventory levels and stretched lead times leave "no margin for error." Given his view that any lead time adjustment or demand slowdown could drive a "meaningful correction," Moore has downgraded his semiconductor industry view to Cautious from In-Line. He favors connector companies, like Amphenol (APH) and TE Connectivity (TEL) over analog/MCU at this point in the cycle, due to lower risk around lead time issues, Moore said. He also has a "strong preference" for high margin and more defensive models, such as Analog Devices (ADI) over lower margin and commodity exposed ones, like Cypress Semiconductor (CY) and ON Semiconductor (ON), he said. Despite his more cautious view on the space, Moore keeps Overweight ratings on Nvidia (NVDA), Xilinx (XLNX) and Ambarella (AMBA), citing his view that they should benefit from secular growth in the area of AI, data center, and autonomous. Other semiconductor names include Microchip (MCHP), Qorvo (QRVO), Micron (MU), Intel (INTC), Broadcom (AVGO) and Qualcomm (QCOM).
08/09/18
GSCO
08/09/18
DOWNGRADE
Target $44
GSCO
Sell
Seagate downgraded to Sell from Neutral at Goldman Sachs
Goldman Sachs analyst Mark Delaney downgraded Seagate Technology (STX) to Sell and lowered his price target for the shares to $44 from $50, representing 20% downside from current levels. While Seagate has improved its product offerings in the last few years, hard disk drives remain a cyclical industry, and one "facing secular challenges in many parts of the market," Delaney tells investors in a research note. He believes Seagate's fundamentals will peak in the second half of 2018 and decline in 2019. NAND is oversupplied and sold state drive prices are falling, Delaney says. Further, the analyst notes that Seagate trades at a "greater than two turn premium" on forward price-to-earnings ratio relative to peers Western Digital (WDC) and Micron (MU).
WDC Western Digital
$64.98

0.75 (1.17%)

07/27/18
CRSS
07/27/18
DOWNGRADE
CRSS
Hold
Western Digital downgraded to Hold from Buy at Cross Research (pre-open)
07/27/18
BMOC
07/27/18
NO CHANGE
Target $74
BMOC
Market Perform
Western Digital price target lowered to $74 from $90 at BMO Capital
BMO Capital analyst Tim Long lowered his price target on Western Digital to $74 after its below-consensus September quarter guidance, citing weaker environment in mobility resulting in erosion of flash memory average selling prices. The analyst keeps his Market Perform rating, noting that the company's $5B buyback program could support the valuation, but adds that the flash memory business conditions are uncertain.
07/27/18
STFL
07/27/18
NO CHANGE
Target $93
STFL
Buy
Western Digital price target lowered to $93 from $114 at Stifel
Stifel analyst Kevin Cassidy said that Western Digital's (WDC) Q1 guidance missed estimates due to NAND Flash price pressures and noted that management says they are in talks with manufacturing partner Toshiba (TOSBF) to moderate NAND supply growth. He views this discussion as a change in behavior and a positive signal that memory cycles can be dampened as companies focus on ROI rather than market share, Cassidy tells investors. Given his lowered quarterly revenue and non-GAAP EPS estimates, Cassidy cut his price target on Western Digital shares to $93, but he maintains a Buy rating on the stock.
LNG Cheniere Energy
$63.48

-0.13 (-0.20%)

03/26/18
BERN
03/26/18
UPGRADE
BERN
Outperform
Cheniere Energy upgraded to Outperform from Market Perform at Bernstein
03/27/18
03/27/18
UPGRADE
Target $63

Outperform
Cheniere Energy upgraded to Outperform at Bernstein
As previously reported, Bernstein analyst Jean Ann Salisbury upgraded Cheniere Energy to Outperform from Market Perform as lower gas price drives better margins on marketing, and an improved discount rate as US LNG should be the lowest cost supply and thus unlikely to be reneged on. The analyst also raised her price target on the shares to $63 from $55.
03/15/18
03/15/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Radian Group (RDN) initiated with a Neutral at Macquarie. 2. Cheniere Energy (LNG) initiated with a Buy at BofA/Merrill. 3. Avid Bioservices (CDMO) initiated with an Outperform at Wells Fargo. 4. Quintana Energy Services (QES) initiated with an Overweight at Capital One. 5. II-VI (IIVI) initiated with a Buy at DA Davidson. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/05/18
LEHM
07/05/18
NO CHANGE
Target $77
LEHM
Overweight
Cheniere Energy price target raised to $77 from $65 at Barclays
Barclays analyst Christine Cho raised her price target for Cheniere Energy (LNG) to $77 and keeps an Overweight rating on the shares. She also raised her price target for Equal Weight-rated Cheniere Energy Partners (CQP) to $38 from $35 and Equal Weight-rated Cheniere Energy Partners LP (CQH) to $37 from $32. Cho estimates the combination of Train 6 and Cheniere Energy Partners' buy-in will add $440 in discounted cash flow to Cheniere Energy on a pre-tax basis. At a 7.5% discounted cash flow yield, the analyst estimates this equates to about $20 per Cheniere Energy share on an undiscounted basis. She thinks the stock could trade to $100 as 2024 approaches, all else being equal.
WFC Wells Fargo
$58.07

0.43 (0.75%)

07/15/18
KBWI
07/15/18
UPGRADE
Target $63
KBWI
Outperform
Wells Fargo upgraded to Outperform from Market Perform at Keefe Bruyette
Keefe Bruyette analyst Brian Kleinhanzl upgraded Wells Fargo to Outperform and raised his price target for the shares to $63 from $57. The stock closed Friday down 67c to $55.36. Current share levels offer an attractive entry point for a "self-help stock" that can generate "material" earnings growth near-term, Kleinhanzl tells investors in a research note. The analyst saw enough in Wells Fargo's most recent quarter to get him more constructive. He raised his earnings estimates and sees additional upside if management can drive expenses toward the company's investor day simulation range of $50B-$51B in 2020. Kleinhanzl sees expense saves and capital returns driving shares of Wells Fargo higher.
07/16/18
BMOC
07/16/18
NO CHANGE
Target $61
BMOC
Market Perform
Wells Fargo price target raised to $61 at BMO Capital after in-line Q2
BMO Capital analyst James Fotheringham kept his Market Perform rating and nudged his price target on Wells Fargo (WFC) to $61 from $59 after the company's in-line Q2 "core" results which also showed higher than expected net interest margins and lower loss provisions. The analyst notes that after relative underperformance by the financials sector this year, he would recommend that investors buy "inexpensive stocks with near-term catalysts", including Santander (SC), OneMain (OMF), and Synchony (SYF).
07/16/18
07/16/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Wells Fargo (WFC) upgraded to Outperform from Market Perform at Keefe Bruyette with analyst Brian Kleinhanzl saying current share levels offer an attractive entry point for a "self-help stock" that can generate "material" earnings growth near-term. 2. VF Corp. (VFC) upgraded to Overweight from Neutral at JPMorgan with analyst Matthew Boss saying he sees an attractive risk/reward profile at current share levels given the company's "multi-year inflection." 3. UPS (UPS) upgraded to Buy from Neutral at UBS with analyst Thomas Wadewitz saying the combination of cost and productivity improvements, coupled with a constructive" revenue backdrop, provide potential for improved Domestic Package margin performance and stronger operating income growth in 2019 for UPS. 4. Autoliv (ALV) upgraded to Outperform from Neutral at Daiwa. 5. Saratoga Investment (SAR) upgraded to Buy from Neutral at Compass Point. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/20/18
OPCO
07/20/18
NO CHANGE
OPCO
Perform
Wells Fargo's next few earnings reports likely to be 'choppy,' says Oppenheimer
Oppenheimer analyst Chris Kotowski maintained a Perform rating on Wells Fargo (WFC) after recent meetings with CFO John Shrewsberry. In a research note to investors, Kotowski says there was nothing that shakes his view that the next few quarterly earnings reports are likely to still be "choppy," and notes that Shewsberry "readily acknowledged" that there was much work to be done to get the consent order lifted. At the same time, the analyst contends that shares are not trading at much of a discount versus other high performing banks like JPMorgan (JPM) and PNC (PNC) and says he favors companies that have lower but rising ROTCEs that are trading near TBV, especially Citi (C), CIT (CIT) and Goldman (GS).
PAH Platform Specialty Products
$12.26

0.08 (0.66%)

11/15/17
11/15/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Albireo Pharma (ALBO) initiated with a Buy at Roth Capital. 2. Qudian (QD) was initiated with a Buy at Stifel and an Equal Weight at Morgan Stanley. 3. Platform Specialty Products (PAH) reinitiated with a Neutral at Credit Suisse. 4. Karyopharm (KPTI) assumed with a Buy at H.C. Wainwright. 5. Extraction Oil & Gas (XOG) initiated with an Outperform at Imperial Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/23/18
GSCO
07/23/18
DOWNGRADE
Target $14
GSCO
Neutral
Platform Specialty Products downgraded to Neutral from Buy at Goldman Sachs
Goldman analyst Robert Koort downgraded Platform Specialty Products to Neutral and maintained a $14 price target following the agreement to sell its Agricultural Solutions segment to UPL Limited for $4.2B in cash. Koort now sees fewer catalysts near-term as the company works through the regulatory process in order to close the deal.
11/15/17
FBCO
11/15/17
INITIATION
Target $12
FBCO
Neutral
Platform Specialty Products reinitiated with a Neutral at Credit Suisse
Credit Suisse analyst Christopher Parkinson reinstated coverage of Platform Specialty Products with a Neutral rating and $12 price target.
06/07/18
MSCO
06/07/18
NO CHANGE
Target $12
MSCO
Equal Weight
Morgan Stanley says Platform Specialty investors likely prefer ag business sale
After The Wall Street Journal reported yesterday that Platform Specialty Products is in advanced talks to sell its agricultural unit to Wilmcote Holdings for about $3B, or $4B including debt, Morgan Stanley analyst Neel Kumar noted that the $4B reported offer from Wilmcote is lower than the $4.25B reportedly offered by a consortium led by Blackstone in July 2017. However, he thinks a potential sale could accelerate deleveraging and believes investors likely prefer an outright sale of the ag business to an IPO. Kumar keeps an Equal Weight rating and $12 price target on Platform Specialty shares.
BABA Alibaba
$172.53

-5.12 (-2.88%)

08/14/18
MKMP
08/14/18
NO CHANGE
Target $51
MKMP
Buy
JD.com has 'improving event path' and 'low valuation', says MKM Partners
MKM Partners analyst Rob Sanderson kept his Buy rating and $51 price target on JD.com (JD) ahead of its Q2 earnings this week, saying that while consensus expectations suggest concern with whether net margins can achieve the 0.9%, more bullish investors can be rewarded beyond this quarter. The analyst further notes that the loss of market share to Alibaba (BABA), along with China macro trade concerns, have weighed on the stock, but its "all-time low" valuation is compelling, and even a partial recovery in performance could yield a sizable move in the stock price.
07/09/18
DADA
07/09/18
NO CHANGE
Target $8
DADA
Buy
Groupon offers 'tremendous value' in potential sale, says DA Davidson
DA Davidson analyst Tom Forte kept his Buy rating and $8 price target on Groupon following speculation by Recode over the weekend that the company is looking to sell itself. Forte recommends that investors purchase shares, stating that the market is underpricing Groupon as its "North American business has never been in better shape and its international operations are well positioned". In a bull case, the analyst contends that Groupon could be worth $12 per share if it can improve its growth rate or find a strategic buyer where a deal would value the two companies higher than the sum of their parts. Forte speculates about Priceline (PCLN), Alibaba (BABA), Google (GOOGL), and Facebook (FB) as potential acquirers for Groupon.
07/06/18
RHCO
07/06/18
NO CHANGE
Target $215
RHCO
Buy
Alibaba price target lowered to $215 from $235 at SunTrust
SunTrust analyst Youssel Squali lowered his price target on Alibaba to $215, citing the impact of later than expected closing for Ele.me, whose $9.5B acquisition was announced in early April. The analyst is also tempering his expectations for growth in the Cloud segment while noting the adverse impact of the recent USD strength relative to the Renminbi. Longer term, Squali keeps his Buy rating on Alibaba, pointing to "exciting initiatives" around Ant Financial's new funding at $150B, exclusive online broadcasting rights of the World Cup, and promising initiatives around enterprise and voice.
08/09/18
STFL
08/09/18
DOWNGRADE
Target $2150
STFL
Hold
Booking Holdings downgraded to Hold on slowing growth at Stifel
As previously reported, Stifel analyst Scott Devitt downgraded Booking Holdings (BKNG) to Hold from Buy, citing the slowing growth at the company-formerly-known-as Priceline. Devitt lowered his core bookings growth expectations in 2018 and beyond following the company's Q2 earnings report and cut his price target on Booking shares to $2,150 from $2,332. He sees better large cap opportunities at company's with similar earnings multiples and better growth, such as Alibaba (BABA), Alphabet (GOOGL) and Facebook (FB), Devitt added.
NRG NRG Energy
$32.83

0.33 (1.02%)

07/30/18
SBSH
07/30/18
DOWNGRADE
Target $33
SBSH
Neutral
NRG Energy downgraded to Neutral from Buy at Citi
Citi analyst Praful Mehta downgraded NRG Energy to Neutral while raising his price target for the shares to $33 from $20. The analyst cites valuation for the downgrade but continues to like NRG's business model and low leverage.
08/06/18
SBSH
08/06/18
UPGRADE
SBSH
Buy
NRG Energy upgraded to Buy from Neutral at Citi
05/23/18
BOFA
05/23/18
INITIATION
Target $37
BOFA
Buy
NRG Energy resumed with a Buy, $37 target at BofA/Merrill
BofA/Merrill analyst Julien Dumoulin-Smith resumed coverage of NRG Energy with a Buy rating and $37 price target. The analyst notes NRG's $500M convertible debt note was paired with the completion of a "meaningful portion" of the company's $500M repurchase program, half the $1B expected in 2018. Execution of these buybacks will likely lift the share price in the near-term, Dumoulin-Smith tells investors in a research note. The analyst sees "meaningful upside" in NRG shares as Electric Reliability Council of Texas forwards "continue to climb" in 2018 and 2019.
08/06/18
SBSH
08/06/18
UPGRADE
Target $38
SBSH
Buy
Citi brings NRG Energy back to Buy a week after downgrade
Citi analyst Praful Mehta upgraded NRG Energy to Buy from Neutral and raised his price target for the shares to $38 from $33. The analyst downgraded the shares to Neutral on July 30. In a research note partially titled "We Were Wrong. Story Stronger," Mehta says the strength of NRG's model was shown in last week's Q2 report. The analyst boosted his 2019 EBITDA estimate by $300M and 2020 estimate by $150M. He views his sum-of-the-parts valuation of $38 per share as conservative since it includes no value for buybacks or return on excess cash. NRG's "strong execution and ERCOT tightness" drives the upgrade back to Buy, Mehta tells investors in a research note.
BAC Bank of America
$30.80

0.33 (1.08%)

04/17/18
BMOC
04/17/18
NO CHANGE
Target $34
BMOC
Market Perform
Bank of America is the best of the 'big four' U.S. banks, says BMO Capital
BMO Capital analyst James Fotheringham kept his Market Perform rating and $34 price target on Bank of America (BAC) after its in-line Q1 earnings but raised his FY18 EPS view to $2.62 from $2.59 and FY19 view to $3.18 from $3.12. Fotheringham says than in contrast, he lowered earnings forecasts for JPMorgan (JPM), Wells Fargo (WFC), and Citigroup (C) because of higher costs and lower revenues, but Bank of America's better than expected net interest income rise justifies his view of the bank as the "best of the bunch". The analyst also notes the bank's more favorable valuation trading at a below-average two-year-forward P/E multiple despite his forecast of double the core earnings growth rate of Bank of America's peers.
04/03/18
BMOC
04/03/18
NO CHANGE
Target $34
BMOC
Market Perform
Bank of America pullback provides a buying opportunity, says BMO Capital
BMO Capital analyst James Fotheringham says that the recent near-10% pullback in the Bank of America stock price provides investors with a buying opportunity. The analyst contends that the bank's stock trades much more closely in line with short term interest rates rather than the 10-year and believes that its net interest margins will prove to be "insensitive" to lower yields on the benchmark as well as higher LIBOR-OIS spreads. Fotheringham keeps his $34 price target and Market Perform rating on Bank of America, adding that its current two-year-forward P/E valuation multiple is close to its long-term historical average.
07/17/18
BARD
07/17/18
NO CHANGE
Target $30
BARD
Neutral
Baird would be buyers of Bank of America on weakness
Baird analyst David George said he would remain a buyer of Bank of America shares on any weakness, stating that its operating leverage was impressive in Q2 and should continue along with solid execution. George maintained his Neutral rating and $30 price target on Bank of America shares.
07/09/18
GSCO
07/09/18
NO CHANGE
GSCO
Bank of America, Morgan Stanley top ideas into Q2 earnings season, says Goldman Sachs
Goldman Sachs analyst Richard Ramsden expects Bank of America (BAC) and Morgan Stanley (MS) to beat consensus estimates in Q2. The analyst argues that both appear best positioned, while he sees risk for U.S. Bancorp (USB) and JPMorgan (JPM). Ramsden highlights Bank of America given the material valuation dislocation that looks to support the stock over time. Additionally, the analyst expects an expense and NII beat for Morgan Stanley.
MGM MGM Resorts
$28.99

-0.04 (-0.14%)

08/13/18
FBCO
08/13/18
INITIATION
Target $31
FBCO
Neutral
MGM Resorts initiated with a Neutral at Credit Suisse
Credit Suisse analyst Cameron McKnight started MGM Resorts with a Neutral rating and $31 price target. The analyst thinks MGM is losing some market share in Las Vegas and that Macau could be volatile in the next 12-18 months.
07/05/18
MSCO
07/05/18
NO CHANGE
MSCO
Pullback in Macau gaming names a buying opportunity, says Morgan Stanley
Morgan Stanley analyst Thomas Allen believes the recent selloff in Macau gaming stocks is overdone, as he contends the fact that Macau's gaming revenue growth has missed on the headline for two months in a row is attributable to rising expectations, foreign exchange impacts and likely an improper factoring in of seasonality and the World Cup. Q2 gross gaming revenue growth of 17.2% still beat his forecast of 16%, noted Allen, who said Las Vegas Sands (LVS) continues to be his favored gaming name. He also has an Overweight rating on MGM Resorts (MGM). Allen keeps an Equal Weight rating on Wynn Resorts (WYNN), but sees the stock becoming increasingly attractive if Macau is still "very healthy," as he suspects.
07/20/18
MSCO
07/20/18
NO CHANGE
MSCO
MGM Resorts forecast lowered at Morgan Stanley to account for Macau share loss
Morgan Stanley analyst Thomas Allen, in his preview of Q2 results for the Gaming names he covers, noted that Macau GGR increased 17% in Q2, which was above his estimate of 16% growth. He also said he expects Las Vegas has had a "relatively good" quarter, noting RevPAR in April-May was up 6% and June has a "relatively easy" comparison. Allen lowered his Q2 consolidated property EBITDA estimate for MGM Resorts (MGM) by 2%, factoring in more share loss at the Peninsula property and worse hold as well as lower MGM Cotai EBITDA, and he lowered his price target on MGM to $38 from $39. He raised his Q2 consolidated property EBITDA estimate for Las Vegas Sands (LVS) by 1% and keeps an $86 price target on the stock. He raised his Q2 property EBITDA view for Wynn (WYNN) by 3% and keeps a $200 price target on its shares. Allen has Overweight ratings on Las Vegas Sands and MGM and an Equal Weight rating on Wynn Resorts.
07/11/18
JPMS
07/11/18
NO CHANGE
Target $37
JPMS
Overweight
MGM Resorts should be bought into back half of year, says JPMorgan
JPMorgan analyst Joseph Greff recommends buying shares of MGM Resorts heading into the back half of 2018. The stock offers an attractive risk/reward and setup for 2019, Greff tells investors in a research note. The analyst attributes the 10% year-to-date selloff to MGM's lowered 2018 guidance in April, an "uninspiring" investor day in May, and "disappointing" Macau market-wide gross gaming revenue growth in May and June. He believes most of the issues that have caused 2018's underperformance are transitory and that expectations are "reasonably/incredibly low." Greff lowered his price target for MGM shares to $37 from $41 and keeps an Overweight rating on the name.
ALY Allis-Chalmers
$0.00

(0.00%)

FB Facebook
$181.11

1.03 (0.57%)

08/08/18
CHLM
08/08/18
NO CHANGE
Target $28
CHLM
Sell
Applied Optoelectronics price target raised to $28 from $20 at Craig-Hallum
Craig-Hallum analyst Richard Shannon raised his price target for Applied Optoelectronics (AAOI) to $28 from $20 following a "strong" Q2 result, driven by strong upside from Data Center, specifically Facebook (FB). The analyst thinks most of the upside was from lack of supply from a competitor he believes to be Intel (INTC). He reiterates a Sell rating on Applied Optoelectronics shares.
08/06/18
STFL
08/06/18
NO CHANGE
Target $202
STFL
Buy
Facebook added to Stifel Select List, Amazon removed
Stifel analyst Scott Devitt replaced Amazon (AMZN) with Facebook (FB) on the Stifel Select List, citing the strong year-to-date performance of Amazon shares, which he still likes and keeps a Buy rating upon. He believes Facebook expectations, and the shares, are appropriately set to allow for longer-term outperformance given the material reset that followed the company's "painful" Q2 update, Devitt tells investors. He maintains a Buy rating and $202 price target on Facebook.
08/09/18
BMOC
08/09/18
NO CHANGE
Target $52
BMOC
Outperform
Match Group price target raised to $52 from $45 at BMO Capital
BMO Capital analyst Daniel Salmon raised his price target on Match Group (MTCH) to $52 after its Q2 earnings beat and raised FY18 guidance, saying its Tinder platform continues to exceed expectations while the rest of the portfolio shows stability. Salmon adds that Tinder's subscription growth and pricing power position Match Group as a "sustainable long-term" story within the expanding total addressable market, even as the entry of Facebook (FB) into the online dating industry gets closes. The analyst keeps his Outperform rating on Match Group.
AGN Allergan
$184.44

0.18 (0.10%)

08/03/18
08/03/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Allergan (AGN) upgraded to Buy from Neutral at Mizuho with analyst Irina Koffler saying she views Allergan's risk/reward more favorably following the company's "strong" beat and raise quarter and the delayed introduction of Restasis generics. 2. Pacira (PCRX) upgraded to Buy from Hold at Needham with analyst Serge Belanger citing "strong" Q2 performance of Exparel, where sales growth is accelerating while the company engages more of the anesthesiologist community. 3. Entergy (ETR) upgraded to Buy from Neutral at UBS with analyst Daniel Ford saying the stock no longer warrants a discount associated with nuclear decommissioning and operating performance risk. 4. Eversource (ES) upgraded to Neutral from Underperform at BofA/Merrill with analyst Julien Dumoulin-Smith saying the story has been de-risked with no major capex projects left. 5. TripAdvisor (TRIP) upgraded to Hold from Underperform at Needham with analyst Laura Martin saying while the company's pivot to competing as an online travel agent has failed, its focus to grow its non-hotel businesses is a "higher ROI idea." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/03/18
MZHO
08/03/18
UPGRADE
Target $210
MZHO
Buy
Allergan upgraded to Buy from Neutral at Mizuho
Mizuho analyst Irina Koffler upgraded Allergan to Buy and raised her price target for the shares to $210 from $194. The Botox maker closed yesterday up 29c to $184.28. The analyst views Allergan's risk/reward more favorably following the company's "strong" beat and raise quarter and the delayed introduction of Restasis generics. Further, the company's September 14 Aesthetics Day could drive multiple expansion in the stock, Koffler tells investors in a research note. The analyst likes Allergan's "dominance" in a growing cash pay market, low exposure to near-term rebating pressure, and improving operating margins after "unexpected" strength in the body contouring products in Q2.
08/06/18
CANT
08/06/18
NO CHANGE
Target $180
CANT
Neutral
Allergan depression drugs have billion dollar potential, says Cantor Fitzgerald
Cantor Fitzgerald analyst Louise Chen believes Two of Allergan's depression drugs in development, rapastinel and AGN-241751, have billions of dollars in peak sales potential. These two opportunities are still underappreciated by the Street, Chen tells investors in a research note. She expects positive data for these treatments but keeps a Neutral rating on Allergan shares with a $180 price target.
08/03/18
08/03/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. ALLERGAN UPGRADED TO BUY: Mizuho analyst Irina Koffler upgraded Allergan (AGN) to Buy from Neutral and raised her price target for the shares to $210 from $194. The analyst views Allergan's risk/reward more favorably following the company's "strong" beat and raise quarter and the delayed introduction of Restasis generics. Allergan is up 1.2% in late morning trading. NEEDHAM UPS TRIPADVISOR TO HOLD: Needham analyst Laura Martin upgraded TripAdvisor (TRIP) to Hold from Underperform, saying that while the company's pivot to competing as an online travel agent has failed, its focus to grow its non-hotel businesses is a "higher ROI idea". FLOOR & DECOR DOWNGRADED AT JPMORGAN, PIPER: JPMorgan analyst Christopher Horvers downgraded Floor & Decor (FND) to Neutral from Overweight and lowered his price target for the shares to $45 from $59. The "story shift" taking place is likely to keep the shares in "purgatory," Horvers said following the company's Q2 results. Piper Jaffray analyst Peter Keith also downgraded Floor & Decor to Neutral and lowered his price target for the shares to $39 from $58. The analyst admitted his June upgrade of the stock was wrong following Floor & Decor's Q2 miss and guide down. Floor & Decor is down 6.4% in late morning trading. LUNA CUT TO MARKET PERFORM AT NORTHLAND: Northland analyst Tim Savageaux downgraded Luna Innovations (LUNA) to Market Perform from Outperform as he sees the shares reflecting the value of the "well executed" sale of the Opto Solutions unit at current levels. CANACCORD INITIATES TESLA WITH A HOLD: Canaccord analyst Jed Dorsheimer initiated Tesla (TSLA) with a Hold rating as he sees several risks around the company's financing, cash burn, and general maturity in the industry. Catalysts that could de-risk the shares include shifts in corporate governance, consistent production, and "a CEO who is not working 120 hours per week to hold things together," said Dorsheimer, who set a $336 price target on Tesla shares. BWS SAYS ARLO IPO ESTABLISHES VALUATION CASE FOR NETGEAR: BWS Financial analyst Hamed Khorsand said the pricing of Arlo Technologies' (ARLO) IPO establishes a valuation case for Netgear (NTGR). The analyst believes the IPO pricing gives some context to what Netgear's stake is worth and affirms his sum-of-parts reasoning for owning Netgear shares. He kept a Buy rating on the stock with a $64.50 price target.
GOOG Alphabet
$1,241.95

6.85 (0.55%)

08/07/18
08/07/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. BOFA CUTS ZILLOW TO NEUTRAL: BofA Merrill Lynch analyst Nat Schindler downgraded Zillow (Z, ZG) to Neutral from Buy and cut its price target to $60 from $70 following the Q2 report and reduction in guidance. Schindler said the quarter indicated Zillow is taking longer than expected to ramp up the Homes business, Rentals revenue missed and the outlook was cut, and other revenue also missed, indicating the new construction opportunity is also taking longer to materialize. Zillow Class A shares are down about 17% in late morning trading. MORGAN STANLEY SAYS WAYMO COULD BE WORTH $175B: Morgan Stanley analyst Brian Nowak increased his enterprise value estimate for Alphabet's (GOOG, GOOGL) Waymo unit from $75B for ride sharing only to $175B given his analyses for two other emerging business models, logistics and licensing. He believes Waymo remains on track to launch an autonomous ride hailing service in Phoenix this year and believes this business could be worth about $80B over the long-term. Given his view of Waymo being a key part of Alphabet's long-term value, Nowak raised his sum of the parts valuation to $1,550 from $1,400. He has an Overweight rating and $1,325 price target on Alphabet shares. GOLDMAN RAISES NVIDIA TARGET AHEAD OF EARNINGS: Goldman Sachs analyst Toshiya Hari raised his price target for Nvidia (NVDA) to $324 from $310 ahead of quarterly results. Unlike the past 10 quarters where the company handily beat Street estimates and raised guidance, the analyst expects a "noisy" quarter with the focal points being the upcoming product transition in Gaming, the current product transition in Datacenter, weakness in cryptocurrency mining, and potential disruption from the virus attack at TSMC (TSM). That said, Hari noted that his long-term bull thesis on Nvidia remains intact and reiterated a Buy rating on the shares. ARGUS CUTS CBS TO HOLD: Argus analyst Joseph Bonner downgraded CBS (CBS) to Hold from Buy, noting significant downside risks for the company from both the sexual harassment allegations against CEO Moonves and the board's attempts to prevent the Viacom (VIA, VIAB) merger. Bonner noted that if the Moonves allegations are proven true, he would be immediately dismissed, which could end the board's bid to remain independent and thereby inflict damage on the shareholders.
08/07/18
MSCO
08/07/18
NO CHANGE
Target $1325
MSCO
Overweight
Enterprise value of Alphabet's Waymo raised to $175B at Morgan Stanley
Morgan Stanley analyst Brian Nowak increased his enterprise value estimate for Alphabet's Waymo unit from $75B for ride sharing only to $175B given his analyses for two other emerging business models, namely logistics and licensing. He believes Waymo remains on track to launch an autonomous ride hailing service in Phoenix this year and believes this business could be worth about $80B over the long-term. Partnerships with Walmart (WMT), DDR (DDR) and Peterbilt speak to Waymo's logistics focus, said Nowak, who sees the company potentially having a $90B logistics business. Additionally, he sees a roughly $7B licensing opportunity, pointing to the company's FCA (FCAU) relationship as a model of how companies could pay a license fee to Waymo for its autonomous technology. Given his view of Waymo being a key part of Alphabet's long-term value, Nowak raised his sum of the parts valuation to $1,550 from $1,400. He has an Overweight rating and $1,325 price target on Alphabet shares.
08/06/18
MSCO
08/06/18
NO CHANGE
MSCO
Boeing, Tesla, Nvidia make Morgan Stanley 'key man risk' list
Morgan Stanley equity strategist Mark Savino noted that about 12% of CEO jobs among S&P 500 companies turned over in 2017, noting that this was the highest level of CEO departures since before the financial crisis. The 59 stocks of S&P 500 companies that had CEOs depart in 2017 underperformed the market by 11% over the next 12 months, or since the departure for instances that were less than 12 months ago, noted Savino. In cooperation with the firm's U.S. analysts, Savino and his team identified the companies in each sector they believe face the greatest level of "key man risk," which includes: Boeing (BA), Tesla (TSLA), ADT Inc. (ADT), Moody's (MCO), TransUnion (TRU), Arista Networks (ANET), Church & Dwight (CHD), Coca-Cola (KO), Monster Beverage (MNST), Coupa Software (COUP), Salesforce (CRM), FireEye (FEYE), MongoDB (MDB), Microsoft (MSFT), New Relic (NEWR), XPO Logistics (XPO), Hilton (HLT), Las Vegas Sands (LVS), Best Buy (BBY), Ulta (ULTA), Aflac (AFL), Athene Holding (ATH), Lincoln National (LNC), Arthur J. Gallagher (AJG), Chubb (CB), Amazon.com (AMZN), Activision Blizzard (ATVI), Facebook (FB), Alphabet (GOOGL), Apple (AAPL), Terex (TEX), Cleveland-Cliffs (CLF), Freeport McMoRan (FCX), FleetCor (FLT), Global Payments (GPN), Square (SQ), Jazz Pharmaceuticals (JAZZ), Cheesecake Factory (CAKE), Broadcom (AVGO), Nvidia (NVDA), Chegg (CHGG), DXC Technology (DXC), Medidata (MDSO), Pluralsight (PS), RealPage (RP), Shopify (SHOP) and T-Mobile (TMUS).

TODAY'S FREE FLY STORIES

CMCSA

Comcast

$37.91

0.1 (0.26%)

, CMCSK

Comcast

$0.00

(0.00%)

14:32
09/22/18
09/22
14:32
09/22/18
14:32
Periodicals
Comcast outbids Fox in battle for Sky, Reuters reports »

Comcast (CMCSA; CMCSK)…

CMCSA

Comcast

$37.91

0.1 (0.26%)

CMCSK

Comcast

$0.00

(0.00%)

FOX

21st Century Fox

$43.97

-0.23 (-0.52%)

FOXA

21st Century Fox

$44.33

-0.26 (-0.58%)

SKYAY

Sky

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BOKF

BOK Financial

$104.69

-0.08 (-0.08%)

, COBZ

CoBiz Financial

$23.44

0.01 (0.04%)

13:36
09/22/18
09/22
13:36
09/22/18
13:36
Conference/Events
CoBiz Financial to host special shareholder meeting »

Special Shareholder…

BOKF

BOK Financial

$104.69

-0.08 (-0.08%)

COBZ

CoBiz Financial

$23.44

0.01 (0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 27

    Sep

AMRH

AMERI Holdings

$1.44

-0.04 (-2.70%)

13:30
09/22/18
09/22
13:30
09/22/18
13:30
Conference/Events
AMERI Holdings to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

BRK.A

Berkshire Hathaway

$331,710.00

-1090 (-0.33%)

13:26
09/22/18
09/22
13:26
09/22/18
13:26
Periodicals
Berkshire Hathaway still looks underpriced, Barron's says »

Class A shares of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLGO

BioLargo

$0.00

(0.00%)

13:11
09/22/18
09/22
13:11
09/22/18
13:11
Conference/Events
BioLargo to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CZWI

Citizens Community Bancorp

$14.13

0.03 (0.21%)

12:56
09/22/18
09/22
12:56
09/22/18
12:56
Conference/Events
Citizens Community Bancorp to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SF

Stifel Financial

$54.86

-0.78 (-1.40%)

12:50
09/22/18
09/22
12:50
09/22/18
12:50
Conference/Events
Stifel Financial to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBCT

People's United

$17.94

-0.055 (-0.31%)

, FBNK

First Connecticut

$30.95

0.1 (0.32%)

12:47
09/22/18
09/22
12:47
09/22/18
12:47
Conference/Events
First Connecticut to host special shareholder meeting »

Special shareholder…

PBCT

People's United

$17.94

-0.055 (-0.31%)

FBNK

First Connecticut

$30.95

0.1 (0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 18

    Oct

ASPS

Altisource

$34.10

-0.09 (-0.26%)

12:44
09/22/18
09/22
12:44
09/22/18
12:44
Conference/Events
Altisource to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$217.65

-2.35 (-1.07%)

, CSCO

Cisco

$48.51

0.77 (1.61%)

12:36
09/22/18
09/22
12:36
09/22/18
12:36
Periodicals
Apple, Microsoft among stocks with solid dividends, Barron's says »

Technology stocks are not…

AAPL

Apple

$217.65

-2.35 (-1.07%)

CSCO

Cisco

$48.51

0.77 (1.61%)

IBM

IBM

$151.29

0.12 (0.08%)

MSFT

Microsoft

$114.70

1.13 (0.99%)

ORCL

Oracle

$51.08

0.65 (1.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

  • 26

    Sep

  • 26

    Sep

  • 27

    Sep

  • 03

    Oct

  • 04

    Oct

  • 05

    Oct

  • 10

    Oct

  • 21

    Oct

  • 22

    Oct

  • 22

    Oct

  • 24

    Oct

  • 25

    Oct

  • 28

    Oct

  • 28

    Nov

  • 03

    Mar

CAT

Caterpillar

$156.39

0.38 (0.24%)

, AMAT

Applied Materials

$39.62

0.22 (0.56%)

12:28
09/22/18
09/22
12:28
09/22/18
12:28
Periodicals
Caterpillar, KeyCorp among stocks to buy as bond yields rise, Barron's says »

As the economy improves,…

CAT

Caterpillar

$156.39

0.38 (0.24%)

AMAT

Applied Materials

$39.62

0.22 (0.56%)

BWA

BorgWarner

$45.24

-0.53 (-1.16%)

KEY

KeyCorp

$20.78

0.02 (0.10%)

PH

Parker-Hannifin

$190.52

0.01 (0.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Sep

  • 18

    Oct

  • 25

    Oct

  • 30

    Oct

BSX

Boston Scientific

$37.76

-0.07 (-0.19%)

, ISRG

Intuitive Surgical

$556.70

-4.43 (-0.79%)

10:34
09/22/18
09/22
10:34
09/22/18
10:34
Periodicals
'Good time' to think about device markers, Barron's says »

Medical technology stocks…

BSX

Boston Scientific

$37.76

-0.07 (-0.19%)

ISRG

Intuitive Surgical

$556.70

-4.43 (-0.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

TLRY

Tilray

$123.16

-53.365 (-30.23%)

10:20
09/22/18
09/22
10:20
09/22/18
10:20
Periodicals
Marijuana stocks 'the new Bitcoin,' Barron's says »

Led by Tilray, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$217.65

-2.35 (-1.07%)

, WMT

Walmart

$95.85

0.1 (0.10%)

09:05
09/22/18
09/22
09:05
09/22/18
09:05
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AAPL

Apple

$217.65

-2.35 (-1.07%)

WMT

Walmart

$95.85

0.1 (0.10%)

DE

Deere

$152.82

-1.24 (-0.80%)

AGCO

Agco

$60.24

-0.9 (-1.47%)

ADM

Archer Daniels

$50.33

(0.00%)

MOS

Mosaic

$32.33

0.02 (0.06%)

CF

CF Industries

$52.82

-0.48 (-0.90%)

SPWR

SunPower

$7.88

-0.18 (-2.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 28

    Oct

  • 06

    Nov

  • 13

    Nov

  • 15

    Nov

  • 03

    Mar

AERI

Aerie Pharmaceuticals

$58.50

0.1 (0.17%)

, AGN

Allergan

$191.34

-1.11 (-0.58%)

04:55
09/22/18
09/22
04:55
09/22/18
04:55
Conference/Events
European Society of Retina Specialists to hold a conference »

18th Congress of EURETINA…

AERI

Aerie Pharmaceuticals

$58.50

0.1 (0.17%)

AGN

Allergan

$191.34

-1.11 (-0.58%)

ALIM

Alimera Sciences

$1.07

(0.00%)

BABY

Natus Medical

$34.45

-0.2 (-0.58%)

BHC

Bausch Health

$24.92

-0.07 (-0.28%)

BAYRY

Bayer

$0.00

(0.00%)

ELXMF

Ellex Medical Lasers

$0.00

(0.00%)

GKOS

Glaukos

$58.78

-1.69 (-2.79%)

IRIX

IRIDEX

$6.52

0.08 (1.24%)

JNJ

Johnson & Johnson

$142.85

0.85 (0.60%)

NITE

Nightstar Therapeutics

$25.64

-1.71 (-6.25%)

NVS

Novartis

$85.46

-0.505 (-0.59%)

OCUL

Ocular Therapeutix

$6.45

0.03 (0.47%)

RHHBY

Roche

$0.00

(0.00%)

SHPG

Shire

$178.32

-1.68 (-0.93%)

STAA

STAAR Surgical

$47.00

-0.9 (-1.88%)

TMDI

Titan Medical

$2.24

0.02 (0.90%)

TTNP

Titan Pharmaceuticals

$0.22

-0.2833 (-56.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Sep

  • 25

    Sep

  • 27

    Sep

  • 01

    Oct

  • 03

    Oct

  • 09

    Oct

  • 16

    Oct

  • 22

    Oct

  • 28

    Oct

  • 29

    Oct

  • 15

    Nov

  • 27

    Nov

  • 21

    Dec

  • 28

    Dec

  • 15

    Feb

  • 25

    Feb

CDTI

CDTi

$0.34

0.01 (3.08%)

18:15
09/21/18
09/21
18:15
09/21/18
18:15
Hot Stocks
CDTi sees September 21 as effective date of reverse stock split »

CDTi Advanced Materials…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DUK

Duke Energy

$79.82

-0.81 (-1.00%)

18:08
09/21/18
09/21
18:08
09/21/18
18:08
Hot Stocks
Duke Energy restored nearly 1.8M outages in NC, SC during past week »

Duke Energy crews today…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 02

    Oct

  • 03

    Oct

  • 04

    Oct

  • 11

    Nov

JNJ

Johnson & Johnson

$142.85

0.85 (0.60%)

18:01
09/21/18
09/21
18:01
09/21/18
18:01
Hot Stocks
Johnson & Johnson's Janssen discloses phase 3 study results of Esketamine »

The Janssen…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 28

    Oct

UAL

United Continental

$89.94

0.8 (0.90%)

17:39
09/21/18
09/21
17:39
09/21/18
17:39
Periodicals
United pilots refuse contract changes on regional routes, Reuters says »

United Airlines pilots…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

XLE

Energy Select Sector SPDR

$75.11

0.5132 (0.69%)

, XLU

Utilities SPDR

$53.04

0.2049 (0.39%)

17:36
09/21/18
09/21
17:36
09/21/18
17:36
General news
Week ending ETF Scorecard: Materials outperform, Utlilites slump »

S&P500 SECTORS:…

XLE

Energy Select Sector SPDR

$75.11

0.5132 (0.69%)

XLU

Utilities SPDR

$53.04

0.2049 (0.39%)

IYR

DJ US Real Estate Index Fund

$81.88

-0.06 (-0.07%)

XLP

Consumer Staples Sector SPDR

$55.02

0.1285 (0.23%)

XLY

Consumer Discretionary Sector SPDR

$116.98

-0.4288 (-0.37%)

XLB

S&P Select Materials SPDR

$60.54

-0.1312 (-0.22%)

XLF

Financial Select Sector

$28.73

-0.1175 (-0.41%)

XLV

Health Care Select Sector SPDR

$94.26

0.1571 (0.17%)

XLK

Technology Select Sector SPDR

$74.68

-0.2056 (-0.27%)

XLI

Industrial Select Sector SPDR

$79.71

0.2338 (0.29%)

GLD

SPDR Gold Trust

$113.48

-0.77 (-0.67%)

SLV

iShares Silver Trust

$13.44

-0.01 (-0.07%)

USO

United States Oil Fund

$14.95

0.145 (0.98%)

UNG

United States Natural Gas Fund

$24.60

0.235 (0.96%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$86.24

0.05 (0.06%)

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$114.72

0.04 (0.03%)

TLT

iShares 20+ Year Treasury Bond Fund

$117.12

-0.02 (-0.02%)

IEF

iShares 7-10 Year Treasury Bond ETF

$101.00

0.03 (0.03%)

SHY

iShares 1-3 Year Treasury Bond

$83.05

0.02 (0.02%)

IWD

iShares Russell 1000 Value

$129.51

0.13 (0.10%)

IWF

iShares Russell 1000 Growth

$155.30

-0.55 (-0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OHGI

One Horizon Group

$0.18

-0.0088 (-4.63%)

17:34
09/21/18
09/21
17:34
09/21/18
17:34
Syndicate
Breaking Syndicate news story on One Horizon Group »

One Horizon Group files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYTX

Cytori Therapeutics

$0.41

-0.033 (-7.38%)

17:31
09/21/18
09/21
17:31
09/21/18
17:31
Syndicate
Breaking Syndicate news story on Cytori Therapeutics »

Cytori Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEM

Newmont Mining

$31.56

0.05 (0.16%)

17:22
09/21/18
09/21
17:22
09/21/18
17:22
Syndicate
Breaking Syndicate news story on Newmont Mining »

Newmont Mining files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 25

    Oct

CB

Chubb

$139.87

-0.05 (-0.04%)

17:22
09/21/18
09/21
17:22
09/21/18
17:22
Hot Stocks
Chubb CEO Greenberg sells $8.6M in common stock »

Chubb CEO Evan Greenberg…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VTVT

vTv Therapeutics

$0.80

0.0096 (1.21%)

17:21
09/21/18
09/21
17:21
09/21/18
17:21
Hot Stocks
vTv says FDA advised that azeliragon efficacy be shown in at least 2 trials »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.